Staphylococcal protein A is a significant virulency aspect of Staphylococcus aureus. The spa determinant transcription takes place through the exponential development phase and gets suppressed when the cells enter the post exponential; development phase. Spa expression regulation have been studied to be complex with the process involving several factors which includes MgrA, SarT, SarS, Agr, Rot and SarA. In order to identify the sites of regulation inside the SPA promoter, deletion byproducts analysis of the advocate in host strains lacking in a single or more of the aspects of regulation are researched and various important factors of the regulation of spa were revealed. Transcriptional beginner sites for were determined by primer extension. The aim of the literature is to highlight the differences in SP-A variants regulation.
Regulation of the SP-A gene
The coordination and synthesis of protein A (SPA) in staphylococcus aureus is agr locus precise. Various concepts the SPA gene encoding were presented into Agr- and Agr+ of SPA strain of S.aureus derivatives. There was an expression of a truncated SPA using plasmid located SPA with deletions at the 3-end which was nearly completely intercellular and established the function of C-terminal X.
Delegate your assignment to our experts and they will do the rest.
Surfactant protein A undertake a significant part in functions that are linked with host surfactant and defense. In individuals, SP-A is encoded by two genetic factor which are SftpA 2 and SftpA1. Functional and mechanical alterations between Sftpa 1(SP-A1) and Sftpa2(SP-A2) products have been noticed as well as sequence and splice variation, in a respective manner, at the 5’UTR and 3’UTR ( Jenul & Horswill, 2019). The research was conducted on the function of 3’UTR variants and 5’UTR variants and polyA on translation (Heinrich,2011). There was a generation of constructs (n=14) with the luciferase reporter gene flanked by SPA 3’ UTR and 5’UTR. An Mrna was acquired in vitro and polyA was omitted or added. NCI-H441 cells were transfected and an activity of the luciferase was quantified (Zhu et al., 2019).
Transcription
In the absence of 3’UTR, the SP-A UTRs display addictive effect with polyA and allows for translation stimulation with various efficiencies in the absence of 5’UTR, 3’UTR increased translation with no differences among variants. The mixture of SP-A 5’UTR and 3’UTR exhibited a result which was addictive on translation (Hernandez & Sporandio, 2019). In the research context the SP-A1 6A 3’UTR variant exhibited a higher translation than 6A, whereas no differences were seen between SP-A2 3’UTRs. The polyA, 5’UTR and 3’UTR contributes to the translation which is differentiated of SP-A2 and SP-A1. Nevertheless, the SP-A1 3’UTR seems to regulate the variant specific translation (Silveyra et al., 2010).
The expression of SFTPA1 gene is regulated at various levels which includes translation and stability of mature Mrna, gene transcription and post transcriptional processing. The most vital structures of the human surfactant protein A mRNAs are that they consist of an adjustable 5’UTR which is the five prime untranslated regions generated from splicing variants of exons A, B, C and D. At least 10 kinds of human SFTPA2 and SFTPA1 5’UTRLs have been observed to vary in the length, relative amount and nucleotide sequence. Unique SFTPA2 and SFTPA1 have also been characterized (Wang et al., 2010). Some SFTPA 1 unique 5’UTRs are inclusive of exons C or B’. The two exons consist of upstream AUGs that can potentially act as translation initiation sites, thus affecting the translation of proteins and the relative content of SFTPA1 (Vieira et al., 2017). Most of the transcripts of SFTPA1 do not have the exon B, a sequence which is implicated in translation and transcription enhancement, which indicates a differential regulation of SFTPA2 and SFTPA1 expression.
The AD’ kind is the most represented among the transcripts of SFTPA1 which is about 81% and a research that is experimental have shown that the order can enhance translation and stabilize Mrna but the implications of the mechanisms in the regulation are yet to be determined ( Tredano et al., 2001), whereas the variances at the 5’ UTR are shown to help in the regulation of both translation and transcription, polymorphisms at the 3’UTR of SP-A1 variations are revealed to differentially and primarily affect the efficacy of translation through mechanisms that comprise of the binding of micro RNAs and proteins (Silveyra et al., 2010). The effect of the regulation on SFTPA1 and SFTPA2 levels of proteins might contribute to alterations in individual vulnerability to the lung illness ( Podolec & Ulm, 2018). Ecological pollutants and insults involve the expression of SFTPA1. The exposure of the cells of the lungs to particulate matter affects 5’ UTR splicing of SFTPA1 exons transcripts (Schmid et al., 2017). Viral infections and pollutants also affect the translation mechanisms of SFTPA1.
The proteins that are encoded in the SP A1 gene is mainly synthesized in the lungs type II alveolar cells as a portion of a complex proteins and lipids that are identified as pulmonary surfactant (Ran et al., 2020). The role of the complex is to prevent the collapse during breathing out and lessen the surface tension of the alveoli in the lungs. The component of the protein of the surfactant aids in the innate response of the immune system modulation and inflammatory responses (Said-Salim et al., 2003). The SP A1 is a component of the subfamily of Ctype lectins known as collections. In conjunction with SP A2 they are the utmost numerous pulmonary surfactant proteins. The SP A1 connects to the carbohydrates that are found on the surfaces of various microbes and aids in the defense to fight against pathogens in the respiratory system.
Surfactant homeostasis is vital for survival and breathing in an infant that is born prematurely and also for the maintenance of the health of the lungs, and the normal functioning of the lungs throughout the life of a human being. Alterations in the composition and amount of surfactant can change its function and artel oinked with diseases of the respiratory system ( Mitsuhashi, 2013). The lungs are the main sites for the synthesis of SFTPA1 but the Mrna of SFTPA1 expression has also been detected in the salivary glands, colon, eye, pancreas, prostrate and trachea (Phelps et al., 2013). Using individual surfactant protein monoclonal antibodies and the protein can be identified in the lung club cells alveolar, alveolar macrophages and type II pneumocytes but there was no observation of extrapulmonary SP-A immunoreactivity.
Surfactant protein (SP-A) is commonly located in great oligomeric structures. The matured monomer SP A1 monomer is a 35k protein that differs from SP A2 in four amino acids at the region of coding (Ponnu, 2020). The monomer of SP A1 consists four domains, carbohydrate recognition domain, and a neck region. The domain recognition C terminal carbohydrate allows linkages to several kinds of molecules and microorganisms (Gao & Stewart, 2004). The amino acids alterations that differentiate between SP A1 and SP A2 genes and between their conforming variations that are found at the collagen like domain ( Karinch, & Floros, 1995). The alterations of amino acids differences that help in distinguishing among the SFTPA1 variants are found at the domains which are collagen like and carbohydrate recognition.
Post transcription of SP-A genetic factor
The pulmonary surfactant protein A of humans is programmed by binary genetic factors, SP A1 and SP A2. Research have shown that there is heterogeneity between the two genes in three regions, untranslated 3’UT region, coding and untranslated 5’ UT region. In order to examine fully the variability of the regions, and portray the transcription beginner spot in an individual genetic factor, researchers used a 5’ RACE and primer extension and the Cdna sequenced clones from two people (Kroger, 2017). The cDNAs was prolonged from the transcription beginner spot to around 40% of the 3’UT segment (Heinrich, 2006). The in vitro cDNAs translatability that were carefully chosen were also tested. After statistics analysis, researchers found out that the 5UT genes of SP-A consisted of 4: three A, B, D for SP A2 or A, B, C, D for SP-A1 or of untranslated exons three of which had a length that varied: A, B, D and one of which C is new and the exons were spliced alternatively and the main splice forms and there were variations in the relative frequency among the two genetic factors (Balmer, 2002). The SPA1 uses three sites for transcription with an equal amount of regularity while the SP A2 uses a single one (Gabilly et al., 2019). The variability for splicing happens among people exists three undescribed alleles for the SP A1 gene which includes 6A4, 6A2 and 6A3 and binary amino acids can be used in the discrimination of SP A2 and SPA1 alleles.
Translation of the SP-A gene
The surfactant protein undertakes a huge function in the distinctive immunity of the lungs and functions that are related to surfactant. There are two useful genes SP A2 and spa1. The genes are present in both primates and humans whereby rodents only have a single gene. The single genes SP A2 or SP A1 are functional; and are expressed in vitro. In order to study the roles of the genes in vivo, researchers generated a transgenic humanize mice (Choi et al., 2006). The SPA Cdna in experiment constructs was determined by the SP C 3.7kb advocate constructive mice were bred with SP-A knock out mice to generate F8 progeny for the research. Epithelial type II alveolar cells were positive of the SPA genetic factor and Clara cells were found to be adverse by immunohistochemistry in Htg mice. The SP A stages in the lungs of two in the htg lines in the lungs were incomparable in the lungs of the human beings (Booth et al., 2016). The analysis of southern blot showed that two cdna copies of either SP A2 and SP A1 were combined as a concatemer into the two htg lines concatemer genome. The analysis of the electron microscopy showed that the htg mice with one SP A2 or SP A1 genetic factor product required tubular myelin but htg mice carrying both had TM (Pham et al.,2020). Moreover, TM was detected in human bronchoalveolar lavage fluid only when both the genetic factor products were extant and not only those consisting of SP A1 and SP A2 genetic factor products.
H ow would you consider continuing research in the SP-A field?
To evaluate the effects and significance of fast research and advancements in the edge of assisted production and genetic sand their applications into clinical practice. Researchers should identify significant issues that cover the impacts of expanded carrier screening, direct consumer testing in genetics. Developments in research should be done. Acknowledgements should be made that there is an indistinct boundary between clinical applications and research studies ( Silveyra & Floros, 2012) . Legal and medical liability issues might arise if responsibilities and roles of actors at different translation levels in results of research should be well established.
There still exists gaps in research in the knowledge of how SP-A have effects on the defenses of the host and the types of cells and its impact during the infection of the lungs especially AMs. The AM is the main effecter cell for the insusceptibility of the lungs and displays a exceptional phenotype inclined by SP-A, even though the extent of the impact is not understood clearly. More research should be done in studying the differences between disease susceptibility and differences the functions of the lungs and in incidence, risk and several lung diseases pathogenesis ( Silveyra & Floros, 2012) . Research should also be conducted in animal and human studies to show the increased incidences of respiratory infections. Moreover, research should be done on the potential role of variations in genetics in pathogenesis or pulmonary disease following comparison and evaluation of literature that is currently available.
What message is missing
The human surfactant protein A (SP-A) displays widespread complexity at various stages; size, splicing, hereditary, and composition of protein oligomers. But, its significant and multiple functions in inbound host defense, pulmonary surfactant aspects and inflammation regulation might necessitate such a difficulty from an evolutionary view point ( Silveyra & Floros, 2012) . Therefore, the knowledge of such an intricacy might be significant in the developments of therapeutics and illness diagnostics.
In conclusion, t he SPA determinant transcription takes place through the exponential development phase and gets suppressed when the cells enter the post exponential; development phase. The coordination and synthesis of protein A (SPA) in staphylococcus aureus is agr locus controlled. The expression of SFTPA1 gene is regulated at various levels which includes translation and stability of mature Mrna, gene transcription and post transcriptional processing. More research should be done in studying the differences between disease susceptibility and differences the functions of the lungs and in incidence, risk and several lung diseases pathogenesis
References
Booth, J. L., Umstead, T. M., Hu, S., Dybvig, K. F., Cooper, T. K., Wilson, R. P., & Chroneos, Z. C. (2014). Housing conditions modulate the severity of Mycoplasma pulmonis infection in mice deficient in class A scavenger receptor. Comparative medicine , 64 (6), 424-439.
Choi, E. H., Ehrmantraut, M., Foster, C. B., Moss, J., & Chanock, S. J. (2006). Association of common haplotypes of surfactant protein A1 and A2 (SFTPA1 and SFTPA2) genes with severity of lung disease in cystic fibrosis. Pediatric pulmonology , 41 (3), 255-262.
Gabilly, S. T., Baker, C. R., Wakao, S., Crisanto, T., Guan, K., Bi, K., ... & Niyogi, K. K. (2019). Regulation of photoprotection gene expression in Chlamydomonas by a putative E3 ubiquitin ligase complex and a homolog of CONSTANS. Proceedings of the National Academy of Sciences , 116 (35), 17556-17562.
Gao, J., & Stewart, G. C. (2004). Regulatory elements of the Staphylococcus aureus protein A (Spa) promoter. Journal of bacteriology , 186 (12), 3738-3748.
Heinrich, S. M. (2011). Human SP-A-genes, structure, function-and lung diseases (Doctoral dissertation, lmu).
Hernandez-Doria, J. D., & Sperandio, V. (2018). Bacteriophage transcription factor Cro regulates virulence gene expression in enterohemorrhagic Escherichia coli. Cell host & microbe , 23 (5), 607-617.
Jenul, C., & Horswill, A. R. (2019). Regulation of Staphylococcus aureus virulence. Gram‐Positive Pathogens , 669-686.
Karinch, A. M., & Floros, J. (1995). 5'splicing and allelic variants of the human pulmonary surfactant protein A genes. American journal of respiratory cell and molecular biology , 12 (1), 77-88.
Kröger, C., Kary, S. C., Schauer, K., & Cameron, A. D. (2017). Genetic regulation of virulence and antibiotic resistance in Acinetobacter baumannii. Genes , 8 (1), 12.
McCallum, N., Hinds, J., Ender, M., Berger-Bächi, B., & Meier, P. S. (2010). Transcriptional profiling of XdrA, a new regulator of spa transcription in Staphylococcus aureus. Journal of bacteriology , 192 (19), 5151-5164.
Mitsuhashi, A., Goto, H., Kuramoto, T., Tabata, S., Yukishige, S., Abe, S., ... & Nishioka, Y. (2013). Surfactant protein A suppresses lung cancer progression by regulating the polarization of tumor-associated macrophages. The American journal of pathology , 182 (5), 1843-1853.
Pham, V. N., Paik, I., Hoecker, U., & Huq, E. (2020). Genomic evidence reveals SPA‐regulated developmental and metabolic pathways in dark‐grown Arabidopsis seedlings. Physiologia plantarum , 169 (3), 380-396.
Phelps, D. S., Umstead, T. M., Silveyra, P., Hu, S., Wang, G., & Floros, J. (2013). Differences in the alveolar macrophage proteome in transgenic mice expressing human SP-A1 and SP-A2. Journal of proteomics and genomics research , 1 (2), 2
Podolec, R., & Ulm, R. (2018). Photoreceptor-mediated regulation of the COP1/SPA E3 ubiquitin ligase. Current opinion in plant biology , 45 , 18-25.
Ponnu, J. (2020). Molecular mechanisms suppressing COP1/SPA E3 ubiquitin ligase activity in blue light. Physiologia plantarum , 169 (3), 418-429.
Ran, R., Cai, D., King, S. D., Que, X., Bath, J. M., & Chen, S. Y. (2020). Surfactant Protein A, a Novel Regulator for Smooth Muscle Phenotypic Modulation and Vascular Remodeling. Arteriosclerosis, Thrombosis, and Vascular Biology , ATVBAHA-120.
Said-Salim, B., Dunman, P. M., McAleese, F. M., Macapagal, D., Murphy, E., McNamara, P. J., ... & Kreiswirth, B. N. (2003). Global regulation of Staphylococcus aureus genes by Rot. Journal of bacteriology , 185 (2), 610-619.
Schmid, N., Suppiger, A., Steiner, E., Pessi, G., Kaever, V., Fazli, M., ... & Eberl, L. (2017). High intracellular c-di-GMP levels antagonize quorum sensing and virulence gene expression in Burkholderia cenocepacia H111. Microbiology , 163 (5), 754-764.
Silveyra, P., Wang, G., & Floros, J. (2010). Impact of untranslated regions (UTRs) on differential translation among SftpA1 and SftpA2 gene variants. The FASEB Journal , 24 , 612-27.
Tredano, M., de Blic, J., Griese, M., Fournet, J. C., Elion, J., & Bahuau, M. (2001). Clinical biological and genetic heterogeneity of the inborn errors of pulmonary surfactant metabolism. Clinical Chemistry and Laboratory Medicine (CCLM) , 39 (2), 90-108.
Vieira, F., Kung, J. W., & Bhatti, F. (2017). Structure, genetics and function of the pulmonary associated surfactant proteins A and D: the extra-pulmonary role of these C type lectins. Annals of Anatomy-Anatomischer Anzeiger , 211 , 184-201.
Silveyra, P., & Floros, J. (2012). Genetic variant associations of human SP-A and SP-D with acute and chronic lung injury. Frontiers in bioscience: a journal and virtual library , 17 , 407.
Wang, G., Guo, X., DiAngelo, S., Thomas, N. J., & Floros, J. (2010). Humanized SFTPA1 and SFTPA2 transgenic mice reveal functional divergence of SP-A1 and SP-A2: formation of tubular myelin in vivo requires both gene products. Journal of Biological Chemistry , 285 (16), 11998-12010.
Zhu, Q., Wen, W., Wang, W., & Sun, B. (2019). Transcriptional regulation of virulence factors Spa and ClfB by the SpoVG-Rot cascade in Staphylococcus aureus. International Journal of Medical Microbiology , 309 (1), 39-53.
